NASDAQ:AXSM Investor Alert: Lawsuit Alleges Misleading Statements by Axsome Therapeutics, Inc.
An investor, who purchased NASDAQ:AXSM shares, filed a lawsuit against Axsome Therapeutics, Inc. over alleged violations of Federal Securities Laws.
View full press release